COMMUNIQUÉS West-GlobeNewswire

Precipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment Technology
10/01/2019
Department of Defense Approves Precipio as a Vendor for its Liquid Biopsy Testing NEW HAVEN, Conn., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), today announced [...]
VitalHub Announces Licensing Deal of VH LTC Mobile App to the Elliott Community
10/01/2019
TORONTO, Jan. 10, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce the sale of its VH LTC solution to the Elliott Community, a long-term care home and retirement living [...]
Canada House Partners with HelloMD to Increase Practitioner Availability and Provide Convenience to Medical Cannabis Patients
10/01/2019
TORONTO, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Canada House Clinics Inc., a division of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House”) and HelloMD, a leading online cannabis telehealth company are pleased to [...]
Medigus Announces CEO Chris Rowland to Step Down
10/01/2019
OMER, Israel, Jan. 10, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, announced today [...]
US FDA sets PDUFA date for SCENESSE®
10/01/2019
Priority Review granted for innovative drug, PDUFA date 8 July 2019 Executive summary New Drug Application submitted in accordance with section 505(b) of the Federal Food, Drug, and Cosmetic Act, filed in accordance [...]
Completion of $25 million subscription
10/01/2019
Summit Therapeutics plc (“Summit Therapeutics” or the “Company”) Completion of $25 million subscription Oxford, UK, and Cambridge, MA, US, 10 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in [...]
Shareholder Press Release
10/01/2019
VANCOUVER, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH) advises that Kulwant Malhi (the “ Acquiror ”), through a series of securities acquisition transactions in the share [...]
Emerald Health Therapeutics Closes Emerald Health Naturals Joint Venture
10/01/2019
Joint venture to distribute endocannabinoid-supporting products to Canadian natural health product stores and pharmacies VICTORIA, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“ [...]
miRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen
10/01/2019
50% of cutaneous T-cell lymphoma patients treated with 300mg IV infusion achieved objective response lasting for greater than four months (ORR4) Evidence of disease stabilization in five adult T-cell leukemia/lymphoma [...]
Integra LifeSciences Launches Integra® Titan™ Reverse Shoulder System-S
10/01/2019
PLAINSBORO, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the full market release of the Integra® Titan™ [...]
Holding(s) in Company
10/01/2019
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
OraSure Technologies Earnings Conference Call Invitation
10/01/2019
2018 Fourth Quarter Earnings Conference Call Wednesday, February 6, 2019, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 10, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings [...]
LIDDS employs Head of Business Development
10/01/2019
LIDDS announces today that Markus Thor has been appointed as Head of Business Development and will join the company in March 2019. The employment is a consequence of the enlarged project portfolio and the broad interest [...]
Completion of $25 million Subscription
10/01/2019
Summit Therapeutics plc (“Summit Therapeutics” or the “Company”) Completion of $25 million subscription Oxford, UK, and Cambridge, MA, US, 10 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in [...]
First Asian patient has been included in the global Phase III program for PledOx® and will trigger a milestone payment of 600 MJPY (c.49 MSEK) to PledPharma
10/01/2019
Stockholm, January 10, 2019. PledPharma AB (publ) and Solasia Pharma K.K. announces that the first patient has been included in the global Phase III program for the drug candidate PledOx ® in Japan. This constitutes an [...]
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today
10/01/2019
Amsterdam, The Netherlands - 10 January 2019 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 24 th Tranche of EUR 230,000 is issued as a private placement of 23 convertible notes (the " [...]
Innate Pharma announces its financial calendar for 2019
10/01/2019
INNATE PHARMA ANNOUNCES ITS FINANCIAL CALENDAR FOR 2019 Marseille, France, January 10, 2019, 7:00 AM CET Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its financial calendar for [...]
Innate Pharma annonce son calendrier financier pour 2019
10/01/2019
INNATE PHARMA ANNONCE SON CALENDRIER FINANCIER POUR 2019 Marseille, le 10 janvier 2019, 7h00 CET Innate Pharma SA (la « Société », Euronext Paris : FR0010331421 – IPH) annonce aujourd’hui son calendrier financier pour l [...]
Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock
10/01/2019
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]

Pages